Targeting RAS-ERK pathway alterations with MEK inhibitors to improve chemosensitivity in high grade serous ovarian cancer

Authors:
  • NNNancy Nguyen
    Nancy Nguyen
  • RBRebecca Brooks
    Rebecca Brooks
  • GLGary Leiserowitz
    Gary Leiserowitz
  • JCJeremy Chien
    Jeremy Chien

Abstract
No abstract available